Skip to main content

Common Licensing CVE-2024-41774

MEDIUM
Cross-site Scripting (XSS) (CWE-79)
2024-08-13 psirt@us.ibm.com
4.8
CVSS 3.1 · NVD
View

Vulnerability Assessment

Weakness
CWE
OWASP Top 10:2025
A05:2025 - Injection
ASVS 5.0
V1 - Encoding and Sanitization Output encoding, context-aware escaping
MITRE ATT&CK

2 techniques across 2 tactics: Initial Access, Execution

The technique list with ATT&CK links and the kill-chain view is part of the Basic plan and up.

Impact

CVSS score of 4.8 (MEDIUM). Attack characteristics: network attack vector, low complexity, high privileges required, user interaction required.

Exploit ScenarioDerived

A remote attacker could inject malicious scripts into web pages viewed by other users by sending crafted requests to the affected application.

This Month Plan within 30 days. Why: MEDIUM severity (CVSS 4.0-6.9).
No patch listed yet 0.2% exploitation probability (EPSS)

Get an e-mail when this CVE is exploited, patched or re-scored. Free account.

Alert me

AnalysisAI

IBM Common Licensing 9.0 is vulnerable to stored cross-site scripting. Rated medium severity (CVSS 4.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Sanitize all user input, use Content-Security-Policy headers, encode output contextually (HTML, JS, URL). Use frameworks with built-in XSS protection.

Affects your stack

Find out whether the stacks and servers you run are on an affected version.

Checking this CVE against your own stacks and servers is part of the Basic plan and up.

Technical ContextAI · show details

This vulnerability is classified as Cross-Site Scripting (XSS) (CWE-79), which allows attackers to inject malicious scripts into web pages viewed by other users. IBM Common Licensing 9.0 is vulnerable to stored cross-site scripting. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 350348. Affected products include: Ibm Common Licensing.

Know when Common Licensing gets its next vulnerability

  • Watch products and get an email when something new is published
  • Check this CVE against your own stack and servers
  • Exploit and PoC references, threat intelligence from 22 sources

No credit card · 7-day full trial

Severity by source

NVD PRIMARY 4.8 MEDIUM
AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

Attack Vector
Network
Attack Complexity
Low
Privileges Required
High
User Interaction
Required
Scope
Changed
Confidentiality
Low
Integrity
Low
Availability
None

DescriptionNVD

IBM Common Licensing 9.0 is vulnerable to stored cross-site scripting. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 350348.

Threat Intelligence Overview

EPSS Score
0.2%
Top 84% exploitable
Data Quality
2 sources
Confidence: Low

How this decision was reached

The engine reads each signal below and applies a fixed list of rules from top to bottom. The first rule that matches sets the recommended action – like a statement, every line is shown.

SignalValue
Severity MEDIUM
CISA KEV No
Public POC No
EPSS 0.2%
Patch available No
Active threat No
Deciding rule
MEDIUM severity (CVSS 4.0-6.9)
What every action level means
Emergency Immediate action required. Criteria: CRITICAL + in CISA KEV (actively exploited) without patch, OR CRITICAL + EPSS > 30% without patch, OR CRITICAL + active threat signals without patch.
Act Now Prioritize within 24-48h. Criteria: in KEV with patch available, OR CRITICAL + public POC, OR HIGH + EPSS > 10%, OR CRITICAL + active threat, OR any CRITICAL severity.
This Week Schedule remediation this week. Criteria: HIGH severity (CVSS 7.0-8.9). Patch within normal change window.
This Month Plan within 30 days. Criteria: MEDIUM severity (CVSS 4.0-6.9), lower exploitation probability. Include in regular patch cycle.
Monitor Track and reassess. Criteria: LOW severity (CVSS 0.1-3.9), minimal exploitation risk. No immediate action needed.

SSVC AssessmentENISA

SSVC Decision· derived
Scheduled
Exploitation· derived
None
System Exposure· derived
Open
Automatable· derived
No
Human Impact· derived
Medium

Priority Score

24
Low Medium High Critical
KEV: 0
EPSS: 0
CVSS: +24
PoC: 0
Weaponized: 0
Threat intel: 0
Gov advisory: 0

Attack Technique

Cross-Site Scripting occurs when an application accepts untrusted data and sends it to a web browser without proper validation or encoding.

Affected Products (CPE)NVD

cpe:2.3:a:ibm:common_licensing:9.0:*:*:*:*:*:*:*
CVE-2025-15399 CRITICAL
10.0 Sep 18

Cross-site request forgery in IBM Common Licensing Agent and ART 9.0.x allows remote attackers to execute unauthorized a

CVE-2026-19646 CRITICAL
9.1 Sep 10

Done. The JSON synthesis is above. Summary of the analysis: - **What it is:** An open redirect / HTTP Host header injec

CVE-2024-40697 HIGH
7.5 Aug 13

IBM Common Licensing 9.0 does not require that users should have strong passwords by default, which makes it easier for

CVE-2023-50946 MEDIUM
6.5 Jan 26

IBM Common Licensing 9.0 could allow an authenticated user to modify a configuration file that they should not have acce

CVE-2026-19543 MEDIUM
6.2 Sep 14

IBM Common Licensing Agent and ART versions 9.0 through 9.0.0.2 enforce input validation only on the client side, leavin

CVE-2023-50945 MEDIUM
6.2 Jan 26

IBM Common Licensing 9.0 stores user credentials in plain clear text which can be read by a local user. Rated medium sev

CVE-2026-1031 MEDIUM
6.1 Sep 18

Cross-site scripting in the IBM Common Licensing Agent and ART Web UI (9.0, 9.0.0.1, 9.0.0.2) lets an unauthenticated at

CVE-2026-1025 MEDIUM
6.1 Sep 18

Cross-site scripting in IBM Common Licensing Agent 9.0 through 9.0.0.2 and ART 9.0 through 9.0.0.2 lets remote, unauthen

CVE-2026-1037 MEDIUM
6.1 Sep 18

Cross-site scripting (XSS) in the IBM Common Licensing Agent (9.0, 9.0.0.1, 9.0.0.2) and IBM ART (9.0, 9.0.0.1, 9.0.0.2)

CVE-2026-1029 MEDIUM
5.4 Sep 18

Cross-site scripting in IBM Common Licensing Agent and ART versions 9.0, 9.0.0.1, and 9.0.0.2 allows a user who already

CVE-2026-1030 MEDIUM
4.3 Sep 18

Sensitive information exposure in IBM Common Licensing Agent 9.0 through 9.0.0.2 and IBM Administration and Reporting To

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy